These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 5475862)

  • 1. [Chemotherapy of murine Ehrlich carcinoma and rat Yoshida sarcoma transplanted on hamsters].
    Ondrus B; Oravec C; Cambelová J; Mériová M
    Bratisl Lek Listy; 1970 Sep; 54(3):262-74. PubMed ID: 5475862
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the electrolyte changes in serum and ascites during cytostatic therapy of transplanted tumors].
    Asbach HW
    Arzneimittelforschung; 1968 Sep; 18(9):1180-2. PubMed ID: 5755934
    [No Abstract]   [Full Text] [Related]  

  • 3. Antineoplastic action of methylglyoxal.
    Jerzykowski T; Matuszewski W; Otrzonsek N; Winter R
    Neoplasma; 1970; 17(1):25-35. PubMed ID: 4315796
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ineffectiveness of a drug combination on Yoshida sarcoma and Walker carcinosarcoma 256 of the rat and on Ehrlich carcinoma of the mouse].
    Zeller WJ; Wiessler M; Adzersen KH
    Arzneimittelforschung; 1972 Mar; 22(3):575-7. PubMed ID: 5067931
    [No Abstract]   [Full Text] [Related]  

  • 5. A new antitumour agent: phenazathionium-mustard salt.
    Csaba G; Körösi J
    Neoplasma; 1968; 15(4):443-5. PubMed ID: 5684468
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the problem of the effectiveness of d-glyceraldehyde].
    Brock N; Niekamp T
    Z Krebsforsch; 1965 Jul; 67(1):93-104. PubMed ID: 4221137
    [No Abstract]   [Full Text] [Related]  

  • 7. Host-mediated antitumor action of schizophyllan, a glucan produced by Schizophyllum commune.
    Komatsu N; Okubo S; Kikumoto S; Kimura K; Saito G
    Gan; 1969 Apr; 60(2):137-44. PubMed ID: 5810959
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the combined effects of 5-bromouracil-2-desoxyriboside and x-rays on animal tumors].
    Maass H; Grote KH
    Strahlentherapie; 1967 May; 133(1):102-7. PubMed ID: 5584666
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the tumor-inhibiting effect of ground substance particles. VII. Effect of glucosamine on the Budapest lymphosarcoma-mouse ascites tumor].
    Becker K; Voss H; Lindner J
    Arch Geschwulstforsch; 1964; 22(4):297-306. PubMed ID: 5896909
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental studies on antineoplastic action of N 1 -(2'-tetrahydrofuryl)-5-fluorouracil (FT-207)--effect on experimental tumors].
    Unemi N; Harima K; Daidai Y; Fujihara H; Fujii S
    Gan No Rinsho; 1971 Oct; 17(10):731-42. PubMed ID: 5166828
    [No Abstract]   [Full Text] [Related]  

  • 11. [Magnetically controlled drugs. Theoretical and experimental substantiation (review of the literature)].
    Ternovoĭ KS; Derzhavin AE
    Vrach Delo; 1984 Jun; (6):13-8. PubMed ID: 6474970
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological characteristics of 60Co-gamma-irradiated cyclophosphamide (endoxan) and possibility of its application to cancer treatment].
    Gamo T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Nov; 27(8):1072-82. PubMed ID: 5245249
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies with Proresid (SP-I) in various innoculation tumors].
    Osswald H; Schmähl D
    Med Klin; 1966 Apr; 61(17):681-4. PubMed ID: 5995181
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on anti-tumor activity of soedomycin, a new anti-tumor agent. II. Anti-tumor effect on Ehrlich ascites tumor and Yoshida sarcoma, and an outline of clinical application to human patients with carcinoma.
    Soeda M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Feb; 26(11):1492-501. PubMed ID: 5231928
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the activation of a cytostatic agent (cyclophosphamide-endoxan) by means of ionizing rays. II: The possibility of the use of irradiated endoxan in the therapy of malignant diseases].
    Tachiiri H; Gamo T; Yoshimura S; Shigematsu Y; Hara K; Yoshii G; Iwo K
    Strahlentherapie; 1968 Aug; 136(2):241-9. PubMed ID: 5684526
    [No Abstract]   [Full Text] [Related]  

  • 16. Proliferation kinetics of tumor and host cells after chemotherapeutic treatment.
    Takemitsu A
    Nagoya J Med Sci; 1975 Mar; 37(3-4):59-70. PubMed ID: 1160987
    [No Abstract]   [Full Text] [Related]  

  • 17. [Investigation on radiosensitizing and tumor inhibiting actions of the antioxidant MTDQ (6,6'-methylen-bis/2,2,4-trimethyl-1-1,2-dihydroquinolin) (author's transl)].
    Bär V; Foris G; Erdélyi V; Pollák Z; Eckhardt S
    Arch Geschwulstforsch; 1975; 45(5):489-95. PubMed ID: 1212067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the chemical structure on the biological endency of cytostatic compounds related to dibromomannitol. I. Structure-activity correlations.
    Institóris L; Horváth IP; Csányi E
    Arzneimittelforschung; 1967 Feb; 17(2):145-9. PubMed ID: 5631481
    [No Abstract]   [Full Text] [Related]  

  • 19. Substances with antineoplastic activity. 28. Cytostatic and pharmacologic properties of beta-4-methoxybenzoyl-beta-bromacrylic acid sodium salt.
    Jelínek V; Semonský M; Francová V; Veselá H; Hradil F
    Neoplasma; 1969; 16(2):121-31. PubMed ID: 4308999
    [No Abstract]   [Full Text] [Related]  

  • 20. YOSHIDA SARCOMA AS A TOOL FOR CANCER CHEMOTHERAPY SCREENING.
    KAZIWARA K; WATANABE J; USUI T; KAWAJI H; MATSUMOTO T
    Natl Cancer Inst Monogr; 1964 Dec; 16():263-89. PubMed ID: 14235657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.